Cutaneous Vasculitis in Rheumatoid Arthritis : A Case Induced by Different Biotherapy

Authors

  • Saoussen Miladi Faculty of Medicine of Tunis, University of Tunis El Manar, Research Unit UR17SP04, 2010 Ksar Said, Tunis, Tunisia and Rheumatology Department. Mongi Slim Hospital, Tunisia.
  • Kaouther Maatallah Faculty of Medicine of Tunis, University of Tunis El Manar, Research Unit UR17SP04, 2010 Ksar Said, Tunis, Tunisia and Rheumatology Department, Kassab Institute, Tunisia.
  • Wafa Hamdi Faculty of Medicine of Tunis, University of Tunis El Manar, Research Unit UR17SP04, 2010 Ksar Said, Tunis, Tunisia and Rheumatology Department, Kassab Institute, Tunisia.

DOI:

https://doi.org/10.9734/bpi/rdmmr/v9/4969F

Keywords:

Cutaneous vasculitis, paradoxical effect, biotherapy, rheumatoid arthritis

Abstract

Biological disease modifying anti-rheumatic drugs (bDMARDs) have improved outcome of rheumatoid arthritis (RA). Cutaneous vasculitis is a manifestation of RA. Besides, it has been described as a paradoxal effect of biotherapy. Vasculitis has been reported with anti-TNF (Tumor Necrosis Factor) agents among more than 140 cases according to the BIOGEAS study group (a Study Group on Autoimmune Diseases of the Spanish Society of Internal Medicine) but only in two cases with Tocilizumab (TCZ). We report the first case of cutaneous vasculitis occurring under both anti-TNF therapy and TCZ.

Published

2021-10-29

How to Cite

Saoussen Miladi, Kaouther Maatallah, & Wafa Hamdi. (2021). Cutaneous Vasculitis in Rheumatoid Arthritis : A Case Induced by Different Biotherapy. Recent Developments in Medicine and Medical Research Vol. 9, 177–181. https://doi.org/10.9734/bpi/rdmmr/v9/4969F

Issue

Recent Developments in Medicine and Medical Research Vol. 9

Section

Chapters